Recommended

FDA tightens COVID vaccine use
Decentralised manufacturing consortium launched
Trial boost for myasthenia gravis drug
FDA starts publishing daily AE data
WEBINAR | The Future of Sterility Testing: One-Day Results with Advanced RT-rt PCR Technology | 5 NOV
WEBINAR | Mastering Impurity Profiling: USP’s Evolving Standards and Strategies | 15 OCT

List view / Grid view

Manufacturing

 

article

The threat of antibiotic resistance

27 April 2016 | By Victoria White, Digital Content Producer

We've created an infographic on the threat of antibiotic resistance, highlighting some of the recommendations made by the Review on AMR...

Optimizing quality and production with Russell Finex sanitary screener
Optimizing quality and production with Russell Finex sanitary screener
news

Optimising quality and production with Russell Finex sanitary screener

25 April 2016 | By

When Enzymatic Therapy stopped outsourcing and built its own FDA-approved manufacturing facility, the goal was to improve product quality, streamline production, and ramp up sales growth. A crucial step was selecting the right pharmaceutical sieving equipment to remove any agglomerates, oversize particles or contaminants from incoming raw dry materials.

news

Aprecia’s 3D-printed Spritam now available in the US

24 March 2016 | By Victoria White

Aprecia’s Spritam (levetiracetam) tablets, for oral suspension, are now available in the US as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures.

article

The application of skip testing to drug substance manufacture

29 February 2016 | By Phil Borman, Simon Bate and Keith Freebairn, GlaxoSmithKline

Skip testing is a process employed to reduce the analytical drugs testing burden and lends itself to processes with high frequency batch production. Rather than test all batches within a given interval, pre-selected batches are assessed and the other batches ‘skipped’. This reduction is justified as it is shown that…

The challenges of riskbased environmental monitoring in sterile product filling
The challenges of riskbased environmental monitoring in sterile product filling
article

The challenges of riskbased environmental monitoring in sterile product filling

29 February 2016 | By

Completing risk assessments is an inherent part of good manufacturing practice (GMP) and risk-based environmental control and monitoring (EM) in sterile product filling within isolators and restricted access barrier systems (RABS). This article considers the challenges the pharmaceutical industry faces in characterising conventional risk assessments like failure modes and effects…

Industrial Pharmaceutical Sieves for Powders at GSK
Industrial Pharmaceutical Sieves for Powders at GSK
news

Industrial pharmaceutical sieves for powders at GSK

26 February 2016 | By

GlaxoSmithKline is improving process efficiency in the production of pharmaceutical powders at its “centre of excellence” plant in Dartford, Kent, by investing in nine new industrial pharmaceutical sieves fitted with the Vibrasonic® Deblinding System from Russell Finex...